Ranitidine, commonly known by the brand name Zantac, was a medication used to decrease the amount of acid produced in the stomach [1]. It belonged to a class of drugs called H2 blockers [2].
What conditions did ranitidine treat?
Ranitidine was prescribed for the treatment of various conditions related to excess stomach acid. These included:
* Peptic Ulcers: Both duodenal and gastric ulcers, which are sores that develop on the lining of the stomach or the first part of the small intestine [1].
* Gastroesophageal Reflux Disease (GERD): A chronic condition where stomach acid frequently flows back into the esophagus, the tube connecting the throat and stomach. This can cause heartburn and other symptoms [1].
* Zollinger-Ellison Syndrome: A rare disorder where one or more tumors called gastrinomas in the pancreas or duodenum cause the stomach to produce too much acid [1].
* Heartburn: Ranitidine was also used for the short-term relief of heartburn [1].
Why was ranitidine recalled?
Ranitidine was voluntarily recalled from the market in 2019 due to concerns about contamination with N-Nitrosodimethylamine (NDMA), a probable human carcinogen [3]. The U.S. Food and Drug Administration (FDA) found unacceptable levels of NDMA in some ranitidine products and determined that the drug posed an unreasonable risk to public health [3]. This led to its removal from pharmacies and retail shelves [3].
What are alternatives to ranitidine?
Following the recall of ranitidine, several alternatives are available for managing conditions previously treated by the drug. These include other H2 blockers and proton pump inhibitors (PPIs).
* Other H2 Blockers: Medications like famotidine (Pepcid) and cimetidine (Tagamet) work similarly to ranitidine by reducing stomach acid production and remain available [4].
* Proton Pump Inhibitors (PPIs): Drugs such as omeprazole (Prilosec), esomeprazole (Nexium), lansoprazole (Prevacid), and pantoprazole (Protonix) are generally more potent in reducing stomach acid and are often prescribed for more severe GERD or ulcers [4].
What is the difference between ranitidine and other acid reducers?
Ranitidine, famotidine, and cimetidine are all H2 blockers, meaning they block histamine H2 receptors in the stomach lining, which signals the stomach to produce acid [2]. Proton pump inhibitors, on the other hand, work by blocking the proton pumps that are the final step in acid production [2]. PPIs typically reduce acid production more effectively and for a longer duration than H2 blockers [4].
When did ranitidine patents expire?
Information on the specific patent expiry dates for ranitidine is available from sources like DrugPatentWatch.com [5]. However, given that ranitidine has been on the market for several decades, its primary patents likely expired long before its market withdrawal. The availability of generic versions of ranitidine before its recall indicates that patent protections had lapsed [5].